Electrochemical Biosensors Market Research Report - Global Forecast till 2027

Electrochemical Biosensors Market: Information by Application (Diagnosis, Monitoring and others), End User (Point of Care Testing, Diagnostics Center, Research Laboratories and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/LS/2075-CR | August 2019 | Region: Global | 98 pages

Electrochemical Biosensors Market Analysis


Electrochemical Biosensor comprises of conductors that conveys the electrical signals which are transformed through the chemical substances and solutions. Electrochemical biosensors diagnose diverse molecules produced within a man such as DNA, glucose, uric acid, cholesterol, hemoglobin, etc. They are used as a therapeutic device that helps in treating several diseases relating to the disproportion of biomolecules.


Some types of electrochemical biosensors are Enzyme-based electrochemical biosensors, DNA electrochemical biosensors, thin-film electrochemical biosensors, aptamer-based biosensors. These biosensors use specimens such as tissues, enzymes, proteins, and whole cells to convert the chemical signals to electrical waves. It is installed in micro-scale devices and is used for the detection of several diseases. Electrochemical biosensors market size is anticipated to observe a growth of CAGR of 10.5% globally. The market is expected to reach USD 30,907.3 Million by the end of the year 2025.


Covid19 Analysis


In the present scenario of the coronavirus, the global pandemic, QRT-PCR, and antigen tests are being conducted for diagnosing the presence of SARS-CoV-2. Electrochemical biosensors are acting as a substitute method for detecting viral infections or antigens inside a person’s body. This method can provide us with immediate results within the time of few minutes to 1 hour. It has increased the electrochemical biosensors market size globally.


Market Dynamics


Drivers


The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, and diseases such as diabetes and heart problems is directly growing the demand for electrochemical biosensors. Diabetes raises the blood sugar level of a person and can harm the nervous system, kidneys, and eyes. The diabetic population is shooting up with every passing day.  In 2013, a report published by the International Diabetes Federation (IDF) says that approximately 384 million people were ailing from diabetes. It is forecasted that 592 million people will have diabetes by the year 2035. This becomes the major driving force in the electrochemical biosensors market’s growth.


Opportunities


Electrochemical biosensors are being used for the precise detection of diseases. Obesity, cardiovascular diseases, high blood pressure, and other such problems which are caused due to unhealthy practices and lifestyle are increasing with every passing day. The detection of the problem becomes vital. It is, therefore, advancing the electrochemical biosensors market worth.


Restraints


With developing infrastructure in every part of the world, it becomes necessary to provide standardized products for medical diagnosis and treatment. The stringent regulatory frameworks and other quality control policies are working as an obstruction in electrochemical biosensors market growth.


Value Chain Analysis


Electrochemical biosensor’s product development and usage ensure that the results inferred are uniform and consistent. These are also accurate in the diagnosis of cancer and can aim directly at the target area. The monitoring and screening of infectious diseases are also done by the electrochemical biosensors in an error-free manner.


Electrochemical Biosensors Market Size, by Application, 2018 (USD Million)  Electrochemical Biosensors Market


Source: MRFR Analysis


Market Segmentation


The electrochemical biosensors market can be classified into various segments. These are: based on application, and based on the end-users.


Based on application


It can be further subdivided into two types, namely, diagnosis and monitoring. The segment related to diagnosis was rated to a market value of USD 8,207.2 million in the year 2018. Diagnosis helps us to recognize the signs and symptoms of a certain disease. It can, thus, be treated accordingly. It also keeps an eye on the growing and decreasing contents in diverse biomolecules produced in the human body. It is, therefore, helping in monitoring the molecules such as DNA, enzymes, blood hemoglobin level, etc.


Based on end-users


Electrochemical biosensors are used by various consumers. They are used at Point of Care Testing (POCT) as they provide us with immediate results of the tests. Biosensors are also used at diagnostics centers and pathological labs. Research laboratories and other academic institutions also provide a market for electrochemical biosensor review.


Europe Electrochemical Biosensors Market Share, by Country, 2018 (%)  Electrochemical Biosensors Market


Source: MRFR Analysis


Regional Analysis


Electrochemical biosensors are leaving their impression in every corner of the world. The regions where they have a stronghold include North America, Europe, Asia-pacific, Middle-East, and Africa.


North America, which includes the region of the US and Canada, has the largest market share because people living in these regions are recognizing the need of adapting to a healthy lifestyle. Due to the widespread infectious, chronic, and lifestyle diseases, the consumption of electrochemical biosensors is highest in these regions. The robust medical infrastructure administers the demand for adequate testing and results.


The European region, which includes Germany, UK, France, Russia, and Italy, holds the position of second-largest market share in the electrochemical biosensors market globally. It is because of the increased geriatric population across the continent. Italy, alone, had a market share of 13.6% in the year 2018.


Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for electrochemical biosensors. It is because of a large population and growing concerns for health issues. It is anticipated to grow tremendously throughout the forecast. This region also provides a competitive market for businesses because of fewer restrictions and laws for carrying out operations.


The Electrochemical biosensors market in the Middle East and Africa is expanding at a moderate pace but is full of promises for the coming future. This is because there are many developing nations in this region.


Competitive Landscape


The list of major key players involved in the market are as follows:



  • Siemens Healthineers (Germany)

  • Abbott Laboratories (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Medtronic PLC (Ireland)

  • Bayer AG (Germany)

  • I-SENS, Inc. (South Korea)

  • Roche (Switzerland)

  • Bio-Rad Laboratories, Inc. (US)

  • DuPont (US)

  • Biosensors International Group, Ltd. (Singapore)

  • Dexcom, Inc. (US)

  • Lifescan IP Holdings, LLC (US)

  • Masimo (US)

  • Nova Biomedical (US)

  • Universal Biosensors (Australia)


The above-listed companies work on the monitoring and origination of new equipment in the electrochemical biosensors market. They invest in the latest technologies to meet the standards of the medical agencies by providing good quality products. Electrochemical biosensors are proven to increase the accuracy in testing as they change the chemical signals from inside the human body to the electric sequel.


Recent Development


Various developments which are found in the Electrochemical biosensors analysis are as follows:



  • In the year 2020, Roche and Sysmex came together and undersigned a Global Partnership Agreement (GBP) to provide a hematology testing solution. They are providing an improved artificial intelligence and monitoring system for increased accuracy and drawing precise conclusions.

  • In June of the year 2019,Abbott sent into orbit the first-ever speedy point-of-care HbA1c Test which helps in detecting diabetes. It enables the pathological labs to build a blueprint based on each individual’s specific case.

  • In December of the year 2020, Abbott introduced sensor-based glucose observing technology, FreeStyle Libre 2. It was also acclaimed by Health Canada for diagnosing diabetes in adults and children above the age of 4 years.

  • In December of 2020, Bio-Rad Laboratories came into a joint venture with Siemens Healthineers, to provide them with a more precise quality control model for their Atellica Solution.


Report Overview


This market research report of the Electrochemical biosensors market includes the following elements:



  • Market Overview

  • COVID19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This electrochemical biosensors market research report sets forth the various types of electrochemical biosensors, which are, namely, enzyme-based electrochemical biosensors, DNA electrochemical biosensors, thin-film electrochemical biosensors, aptamer-based biosensors. It also shows how electrochemical biosensors are acting as a substitute method for detecting viral infection or antigens inside a person’s body during the coronavirus, a global pandemic. As obesity, cardiovascular diseases, high blood pressure, and other unhealthy lifestyle diseases are increasing the need for their monitoring and control is also rising. This is leading to market growth.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 30,907.3 Million
  CAGR   CAGR of 10.5% (2019-2025)
  Base Year   2019
  Forecast Period   2020-2026
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Siemens Healthineers (Germany), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic PLC (Ireland), Bayer AG (Germany), I-SENS, Inc. (South Korea).
  Key Market Opportunities   POCT testing offers various advantages such as cost reduction for laboratory testing, faster results, and increased patient satisfaction.
  Key Market Drivers

  • Increasing diabetic population, rising prevalence of the chronic and lifestyle-induced disease.
  • Increasing demand for POCT, and growing application of biosensors in various industries


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Electrochemical biosensors market projected to grow at approximately 10.5% CAGR during the assessment period (2020-2027).

    The valuation of the global electrochemical biosensors market is estimated to increase to USD 30,907.3 MN by the end of 2025

    Rising prevalence of chronic & lifestyle diseases, increasing application of biosensors in various industries, and augmenting demand for point-of-care-testing (POCT) devices are major tailwinds pushing the growth of the global electrochemical biosensors market.

    North America holds the largest share in the global electrochemical biosensors market, followed by Europe and the Asia Pacific, respectively.

    Bayer AG (Germany), Medtronic Plc. (U.S.), I-SENS, Inc. (South Korea), F. Hoffmann-La Roche AG (Germany), Abbott (U.S.), and Siemens (U.S.), are some of the top players operating in the global electrochemical biosensors market.

    1 Report Prologue

    1.1 Introduction 9

    1.1.1 Global Electrochemical Biosensors Market, By Application 9

    1.1.2 Global Electrochemical Biosensors Market, By End User 10

    1.1.3 Global Electrochemical Biosensors Market, By Region 11

    2 Introduction

    2.1 Definition 13

    2.2 Scope Of Study 13

    2.3 Research Objective 13

    2.4 Assumptions & Limitations 14

    2.4.1 Assumptions 14

    2.4.2 Limitations 14

    2.5 Market Structure 14

    3 Research Methodology

    3.1 Research Process 15

    3.2 Primary Research 16

    3.3 Secondary Research 16

    4 Market Dynamics

    4.1 Introduction 17

    4.2 Drivers 17

    4.2.1 Increasing Diabetic Population 17

    4.2.2 Rising Prevalence Of Chronic And Lifestyle Induced Disease 18

    4.2.3 Increasing Demand For POCT 19

    4.2.4 Increasing Application Of Biosensors In Various Industries 19

    4.3 Restraints 20

    4.3.1 Strict Regulatory Requirements 20

    4.3.2 Reimbursement Policies Issues In Healthcare Systems 20

    4.4 Opportunities 21

    4.4.1 Opportunity From Increasing Demand Of Personalized Medicine 21

    5 Market Factor Analysis

    5.1 Porters Five Forces Analysis 22

    5.1.1 Bargaining Power Of Buyers 23

    5.1.2 Bargaining Power Of Suppliers 23

    5.1.3 Threat Of New Entrants 23

    5.1.4 Intensity Of Rivalry 23

    5.1.5 Threat Of Substitutes 24

    6 Electrochemical Biosensors Market, By Application

    6.1 Introduction 25

    6.2 Diagnosis 26

    6.3 Monitoring 27

    6.4 Other Applications 27

    7 Electrochemical Biosensors Market, By End User

    7.1 Introduction 29

    7.2 Point Of Care Testing 30

    7.3 Diagnostics Center 31

    7.4 Research Laboratories 32

    8 Global Electrochemical Biosensors Market, By Region

    8.1 Introduction 33

    8.2 North America 34

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.2.1 US 37

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.2.2 Canada 38

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3 Europe 39

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3.1 Germany 41

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3.2 France 42

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3.3 UK 43

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3.4 Italy 44

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3.5 Spain 45

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.3.6 Rest Of Europe 46

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.4 Asia-Pacific 48

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.4.1 Japan 50

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.4.2 China 51

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.4.3 India 52

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.4.4 South Korea 53

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.4.5 Rest Of Asia-Pacific 54

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.5 Middle East & Africa 56

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.5.1 Middle East 58

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    8.5.2 Africa 59

    Electrochemical Biosensors Market, By Application

    Electrochemical Biosensors Market, By End User

    9 Competitive Landscape

    9.1 Introduction 60

    10 Company Profile

    10.1 F. Hoffmann-La Roche AG 61

    10.1.1 Company Overview 61

    10.1.2 Product/Business Segment Overview 61

    10.1.3 Financials 61

    10.1.4 Key Developments 62

    10.2 Medtronics 63

    10.2.1 Company Overview 63

    10.2.2 Product/Business Segment Overview 63

    10.2.3 Financial Overview 63

    10.2.4 Key Development 64

    10.3 Bayer AG 65

    10.3.1 Company Overview 65

    10.3.2 Product/Business Segment Overview 65

    10.3.3 Financial Updates 65

    10.4 Abbott Laboratories 67

    10.4.1 Company Overview 67

    10.4.2 Product/Business Segment Overview 67

    10.4.3 Financial Updates 68

    10.5 I-SENS, Inc. 70

    10.5.1 Company Overview 70

    10.5.2 Product/Business Segment Overview 70

    10.5.3 Financial Updates 71

    10.5.4 Key Development 71

    10.6 Siemens Healthcare GmbH 72

    10.6.1 Company Overview 72

    10.6.2 Product/Business Segment Overview 72

    10.6.3 Financial Updates 72

    10.6.4 Key Development 73

    11 List Of Tables

    TABLE 1 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION 2020–2027 (USD MILLION) 26

    TABLE 2 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET FOR DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 26

    TABLE 3 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET FOR MONITORING, BY REGION, 2020–2027 (USD MILLION) 27

    TABLE 4 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 27

    TABLE 5 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER 2020–2027 (USD MILLION) 30

    TABLE 6 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET FOR POINT OF CARE TESTING, BY REGION, 2020–2027 (USD MILLION) 30

    TABLE 7 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET FOR DIAGNOSTICS CENTER, BY REGION, 2020–2027 (USD MILLION) 31

    TABLE 8 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 32

    TABLE 9 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET, BY REGION, 2020–2027 (USD MILLION) 34

    TABLE 10 NORTH AMERICA ELECTROCHEMICAL BIOSENSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 35

    TABLE 11 NORTH AMERICA ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 36

    TABLE 12 NORTH AMERICA ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 36

    TABLE 13 US ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 37

    TABLE 14 US ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 37

    TABLE 15 CANADA ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 38

    TABLE 16 CANADA ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 38

    TABLE 17 EUROPE ELECTROCHEMICAL BIOSENSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 40

    TABLE 18 EUROPE ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 40

    TABLE 19 EUROPE ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 41

    TABLE 20 GERMANY ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 41

    TABLE 21 GERMANY ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 42

    TABLE 22 FRANCE ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 42

    TABLE 23 FRANCE ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 43

    TABLE 24 UK ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 43

    TABLE 25 UK ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 44

    TABLE 26 ITALY ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44

    TABLE 27 ITALY ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 45

    TABLE 28 SPAIN ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 45

    TABLE 29 SPAIN ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 46

    TABLE 30 ROE ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 46

    TABLE 31 ROE ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 47

    TABLE 32 ASIA-PACIFIC ELECTROCHEMICAL BIOSENSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 49

    TABLE 33 ASIA-PACIFIC ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 49

    TABLE 34 ASIA-PACIFIC ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 50

    TABLE 35 JAPAN ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 50

    TABLE 36 JAPAN ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 51

    TABLE 37 CHINA ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51

    TABLE 38 CHINA ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 52

    TABLE 39 INDIA ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 52

    TABLE 40 INDIA ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 53

    TABLE 41 SOUTH KOREA ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53

    TABLE 42 SOUTH KOREA ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 54

    TABLE 43 ROA ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54

    TABLE 44 ROA ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER, 2020–2027 (USD MILLION) 55

    TABLE 45 MIDDLE EAST & AFRICA ELECTROCHEMICAL BIOSENSORS MARKET, REGION, 2020–2027 (USD MILLION) 56

    TABLE 46 MIDDLE EAST & AFRICA ELECTROCHEMICAL BIOSENSORS MARKET, APPLICATIONS, 2020–2027 (USD MILLION) 57

    TABLE 47 MIDDLE EAST & AFRICA ELECTROCHEMICAL BIOSENSORS MARKET, END USER, 2020–2027 (USD MILLION) 57

    TABLE 48 MIDDLE EAST ELECTROCHEMICAL BIOSENSORS MARKET, APPLICATION, 2020–2027 (USD MILLION) 58

    TABLE 49 MIDDLE EAST ELECTROCHEMICAL BIOSENSORS MARKET, END USER, 2020–2027 (USD MILLION) 58

    TABLE 50 AFRICA ELECTROCHEMICAL BIOSENSORS MARKET, APPLICATION, 2020–2027 (USD MILLION) 59

    TABLE 51 AFRICA ELECTROCHEMICAL BIOSENSORS MARKET, END USER, 2020–2027 (USD MILLION) 59

    TABLE 52 MEDTRONICS: KEY DEVELOPMENT 64

    TABLE 53 I-SENS: KEY DEVELOPMENT 71

    TABLE 54 SIEMENS: KEY DEVELOPMENT 73

    12 List Of Figures

    FIGURE 1 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET SHARE, BY APPLICATION, 2018 (%) 10

    FIGURE 2 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET SHARE, BY END USER, 2018 (%) 11

    FIGURE 3 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET SHARE, BY REGION, 2018 (%) 12

    FIGURE 4 RESEARCH PROCESS 15

    FIGURE 5 DRIVERS & RESTRAINTS IMPACT ANALYSIS OF GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET 17

    FIGURE 6 NUMBER OF PEOPLE SUFFERING FROM DIABETES AGED 20-79 YEARS, 2013 AND 2035 18

    FIGURE 7 PORTERS FIVE FORCES ANALYSISOF GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET 22

    FIGURE 8 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET, BY APPLICATION, 2018 AND 2027 25

    FIGURE 9 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET, BY END USER 2018 AND 2027 29

    FIGURE 10 GLOBAL ELECTROCHEMICAL BIOSENSORS MARKET SHARE, BY REGION, 2018 (%) 33

    FIGURE 11 NORTH AMERICA ELECTROCHEMICAL BIOSENSORS MARKET, BY COUNTRY, 2018 (%) 35

    FIGURE 12 EUROPE ELECTROCHEMICAL BIOSENSORS MARKET, BY COUNTRY, 2018 (%) 39

    FIGURE 13 ASIA-PACIFIC ELECTROCHEMICAL BIOSENSORS MARKET, BY COUNTRY, 2018 (%) 48

    FIGURE 14 MIDDLE EAST & AFRICA ELECTROCHEMICAL BIOSENSORS MARKET, REGION, 2018 (%) 56

    FIGURE 15 F. HOFFMANN-LA ROCHE AG.: RECENT FINANCIALS 61

    FIGURE 16 F. HOFFMANN-LA ROCHE AG.: BUSINESS REVENUE 62

    FIGURE 17 F. HOFFMANN-LA ROCHE AG.: GEOGRAPHICAL REVENUE 62

    FIGURE 18 MEDTRONICS: RECENT FINANCIAL 63

    FIGURE 19 MEDTRONICS: OPERATING SEGMENTS 64

    FIGURE 20 MEDTRONICS: GEOGRAPHICAL MIX 64

    FIGURE 21 BAYER CROPSCIENCE: FINANCIAL REVENUE 65

    FIGURE 22 BAYER CROPSCIENCE: SEGMENTAL REVENUE 66

    FIGURE 23 BAYER CROPSCIENCE: GEOGRAPHICAL REVENUE 66

    FIGURE 24 ABBOTT LABORATORIES: FINANCIAL REVENUE 68

    FIGURE 25 ABBOTT LABORATORIES: SEGMENTAL REVENUE 68

    FIGURE 26 ABBOTT LABORATORIES: GEOGRAPHICAL REVENUE 69

    FIGURE 27 I-SENS: FINANCIAL REVENUE 71

    FIGURE 28 SIEMENS: FINANCIAL REVENUE 72

    FIGURE 29 SIEMENS: GEOGRAPHICAL REVENUE 73